LASP1 and neoplasm: It is noteworthy that our in vivo data showed dramatic inhibition of tumor growth by LASP-1 silencing, suggesting that this molecule may be a useful biomarker of proliferation and a possible therapeutic target for developing anti-cancer drugs in human OSCCs because most of our patients with an OSCC have overexpressed LASP-1 protein (Table 1).